COMMUNIQUÉS West-GlobeNewswire

New Clinical Program at Amedisys for Heart Failure Patients Significantly Lowers Risks of Hospitalizations and Readmissions
01/02/2018
BATON ROUGE, La., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Patients diagnosed with heart failure who were enrolled in the new Amedisys Heart Failure program in 2016 and 2017 were significantly less likely to be hospitalized [...]
Progressive Care CEO, S. Parikh Mars Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
01/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD) (the “company”), a healthcare services and technology company, today announced, the release of CEO, Shital Mars’ interview on Uptick Newswire [...]
Actinium Pharmaceuticals Announces Acceptance of Abstract for AACR Annual Meeting Highlighting Superior In Vivo Survival Data for Actinium Labelled Daratumumab Versus Unlabeled Daratumumab, A Blockbuster Product
01/02/2018
- Poster to present additional data showcasing ability of Actinium’s AWE Technology to yield a potential biobetter of daratumumab, a blockbuster CD38 targeted therapy for multiple myeloma NEW YORK, Feb. 01, 2018 (GLOBE [...]
Emerald Health Therapeutics Achieves Tier 1 Listing on TSX Venture Exchange
01/02/2018
VICTORIA, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) has announced that in accordance with TSX Venture Exchange Policy 2.5, the Company has met the [...]
Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons
01/02/2018
Geneva, Switzerland and Boston, MA - February 1, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Nabriva Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
01/02/2018
U.S. Patient Utilization Grew 33%, Year Over Year DANVERS, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today [...]
AxoGen, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
01/02/2018
ALACHUA, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries , today announced that Karen Zaderej [...]
RedHill Biopharma to Present at BIO CEO & Investor Conference
01/02/2018
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vical’s Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis
01/02/2018
SAN DIEGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) and the Mycoses Study Group Education and Research Consortium (MSGERC) today announced the establishment of a collaboration to advance [...]
Coloplast delivers solid Q1 interim results and continues to take market share
01/02/2018
Coloplast delivered 8% organic revenue growth and an EBIT margin of 31% at constant exchange rates in the first quarter of the 2017/18 financial year. The results were in line with the company’s guidance. Coloplast [...]
Announcement no. 02/2018 - Q1 Interim Financial Report, 2017/18
01/02/2018
Q1 2017/18 Interim financial report, Q1 2017/18 (01 October 2017 - 31 December 2017) Please see enclosed pdf. Highlights Coloplast generated 8% organic growth in the first quarter. Reported revenue in DKK was up by 5% [...]
Digirad Corporation Announces Quarterly Dividend of $0.055 Per Share
01/02/2018
SUWANEE, Ga., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) today announced a quarterly cash dividend of $0.055 per share. The dividend is payable on February 28, 2018 to shareholders of record [...]
JOBST Ranked #1 Physician Recommended Compression Therapy Brand in US
01/02/2018
CHARLOTTE, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- BSN medical , a global provider of integrated medical therapy solutions, today announced that its JOBST ® compression therapy line has been ranked the number one [...]
BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M
01/02/2018
CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a Regulation A+ (Mini- [...]
Targovax ASA issues options to employees
01/02/2018
On the basis of the approval by the Annual General Meeting on 5 April 2017 to authorize the Board of Targovax ASA to issue new shares to employees under the Company long-term incentive program, the Board has resolved to [...]
Saniona AB: Saniona's Partner, Medix, Completes Recruitment of Phase 3 Obesity Study of Tesofensine in Mexico
01/02/2018
PRESS RELEASE February 1, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that its partner in Mexico, Medix, has completed recruitment for its Phase 3 clinical study of tesofensine [...]
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders
01/02/2018
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders Shire presentations showcase heritage in Hematology Zug, Switzerland - February 1, 2018 - Shire plc (LSE [...]
DBV Technologies to Attend Upcoming Investor Conferences
01/02/2018
Press Release Montrouge, France, February 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]

Pages